AU4239893A - Bicyclopolyazamacrocyclophosphonic acid complexes, a process for their preparation, and their conjugates, for use as radiopharmaceuticals - Google Patents
Bicyclopolyazamacrocyclophosphonic acid complexes, a process for their preparation, and their conjugates, for use as radiopharmaceuticalsInfo
- Publication number
- AU4239893A AU4239893A AU42398/93A AU4239893A AU4239893A AU 4239893 A AU4239893 A AU 4239893A AU 42398/93 A AU42398/93 A AU 42398/93A AU 4239893 A AU4239893 A AU 4239893A AU 4239893 A AU4239893 A AU 4239893A
- Authority
- AU
- Australia
- Prior art keywords
- radiopharmaceuticals
- conjugates
- preparation
- acid complexes
- bicyclopolyazamacrocyclophosphonic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002253 acid Substances 0.000 title 1
- 229940121896 radiopharmaceutical Drugs 0.000 title 1
- 239000012217 radiopharmaceutical Substances 0.000 title 1
- 230000002799 radiopharmaceutical effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1993/004356 WO1994026755A1 (en) | 1993-05-06 | 1993-05-06 | Bicyclopolyazamacrocyclophosphonic acid complexes, a process for their preparation, and their conjugates, for use as radiopharmaceuticals |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4239893A true AU4239893A (en) | 1994-12-12 |
Family
ID=22236577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU42398/93A Abandoned AU4239893A (en) | 1993-05-06 | 1993-05-06 | Bicyclopolyazamacrocyclophosphonic acid complexes, a process for their preparation, and their conjugates, for use as radiopharmaceuticals |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4239893A (en) |
WO (1) | WO1994026755A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6107482A (en) * | 1995-03-27 | 2000-08-22 | Isis Pharmaceuticals, Inc. | Nitrogenous macrocyclic compounds |
IL126659A (en) * | 1996-04-19 | 2003-05-29 | Dow Global Technologies Inc | Fluorescent chelates as visual tissue specific imaging agents |
MY150861A (en) * | 2012-07-18 | 2014-03-06 | Univ Malaya | Neutron activated 153sm labelled microspheres |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2636632B1 (en) * | 1988-09-16 | 1996-02-02 | Oris Ind | RADIOPHARMACEUTICAL PRODUCTS CONSTITUTED BY TC COMPLEXES, RE OR INCLUDING LETTERS WITH TETRAPHOSPHONATES AND THEIR PREPARATION |
FR2644785B1 (en) * | 1989-03-24 | 1991-07-05 | Guerbet Sa | NOVEL NITROGEN MACROCYCLIC LIGANDS, PROCESS FOR THEIR PREPARATION, METAL COMPLEXES FORMED BY SUCH LIGANDS AND DIAGNOSTIC COMPOSITION CONTAINING THEM |
CA2072080A1 (en) * | 1990-01-19 | 1991-07-20 | Jo Klaveness | Chelating compounds |
GB9001245D0 (en) * | 1990-01-19 | 1990-03-21 | Salutar Inc | Compounds |
US5428139A (en) * | 1991-12-10 | 1995-06-27 | The Dow Chemical Company | Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals |
-
1993
- 1993-05-06 AU AU42398/93A patent/AU4239893A/en not_active Abandoned
- 1993-05-06 WO PCT/US1993/004356 patent/WO1994026755A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1994026755A1 (en) | 1994-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU623766B2 (en) | N-heteroaryl-4-quinolinamines, a process for their preparation and their use as medicaments | |
AU667757B2 (en) | Quinolone- and naphthyridonecarboxylic acid derivatives | |
AU3548993A (en) | Novel alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof | |
AU3354993A (en) | Novel macromolecular polyamine iodine-containing compound, process for its preparation and its use as a contrast agent | |
AU4066089A (en) | Novel tc-99m complexes | |
AU7930394A (en) | Pyrimidinyl-glutamic acid derivatives | |
AU7239794A (en) | Process for preparing 5,8-dihydronaphthoquinone derivatives, novel 5,8-dihydronaphthoquinone derivatives and their use as anticancer agent | |
AU2736895A (en) | Novel chemical compound, its preparation and use as a drug | |
AU3003892A (en) | 1-cyanomethyl-4-carboxymethyl-2-ketopiperazine, salts thereof, and process for their preparation | |
IL94876A0 (en) | Naphthylamino-and naphthyloxy-pyridinamines and related compounds,a process for their preparation and their use as dermatological agents | |
AU2980495A (en) | Granular formulation containing microorganisms, a process for the preparation and the use thereof | |
AU4239893A (en) | Bicyclopolyazamacrocyclophosphonic acid complexes, a process for their preparation, and their conjugates, for use as radiopharmaceuticals | |
AU6190594A (en) | New substituted benzodioxins, a process for their preparation and pharmaceutical compositions containing them | |
AU4237493A (en) | Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as radiopharmaceuticals | |
AU5758894A (en) | Acyloxyhexanoic acid derivatives | |
HRP930131A2 (en) | Amino-ascorbic acid derivatives, process for the preparation and use thereof | |
AU8379091A (en) | New amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same | |
AU5717990A (en) | Magnetic protein conjugates, a process for the preparation thereof and the use thereof | |
AU6840990A (en) | Aminopyridinylmethanols and aminomethylpyridinamines and related compounds, a process for their preparation and their use as medicaments | |
AU1453492A (en) | Antiarteriosclerotic agent, a process for the preparation thereof and the use thereof | |
IL104062A0 (en) | Bicyclopolyazamacrocyclophosphonic acid complexes,their conjugates,processes for their preparation,and use as radiopharmaceuticals | |
AU3049692A (en) | Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same | |
AU5791290A (en) | Phenoxypyridinamines and related compounds, a process for their preparation and their use as medicaments | |
AU609980B2 (en) | Hydrazinocarbonyloxylabdanes, a process for their preparation and their use as medicaments | |
AU2509995A (en) | New cephalosporins containing in position 7 a substituted benzyloxyimino radical, their preparation process, their use as medicaments |